Philips announces new imaging and workflow enhancements for KODEX-EPD cardiac imaging and mapping system to treat heart rhythm disorders
Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced new imaging and workflow enhancements for its novel KODEX-EPD cardiac imaging and mapping system.
August 26, 2020
- New release combines faster, higher resolution imaging for Medtronic cryoablation procedures
- KODEX-EPD system now installed at 40 sites worldwide with over 1500 patients treated
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced new imaging and workflow enhancements for its novel KODEX-EPD cardiac imaging and mapping system. The system is now being used to treat patients with Atrial Fibrillation (AF), a common heart rhythm disorder, at 40 sites worldwide with over 1500 patients treated. The latest release includes improvements in imaging and mapping performance, as well as enhanced features to support cryoablation procedures.
Unlike traditional methods to image the heart during AF procedures such as CT and X-ray fluoroscopy, the KODEX-EPD system uses a combination of sensors attached to the body and catheters inside the heart to image the anatomy and properties of the heart, using innovative dielectric sensing technology. As a result, electrophysiologists can create detailed 3D views of the heart of a patient in as little as three minutes and navigate to the target location more easily and efficiently, with the required precision and without using radiation.
“The new release of the KODEX-EPD system represents a significant step forward in terms of image quality and workflow efficiency for AF procedures, as we continue to work towards our longer term goal of providing real-time therapy assessment,” said Marlou Janssen, General Manager Philips EPD Solutions. “By partnering with Medtronic and developing unique capabilities for cryoablation, we can give more physicians access to this truly innovative cardiac imaging and mapping system, and contribute to delivering efficient workflows with Medtronic’s best-in-class cryoablation therapy.”
Advances in the new release include faster, high-resolution imaging, improvements in mapping functionality and point density, as well as new visualization options such as ‘multi-chamber’ view to help understand the relative positions of adjacent chambers and ‘glass view’, which provides physicians with an improved perception of 3D catheter location and orientation within the heart. For cryoablation procedures, the KODEX-EPD system offers enhanced Occlusion assessment functionality with high accuracy and a simplified workflow [1].
“Using the KODEX-EPD imaging system’s ability to provide high resolution imaging, revealing specific pulmonary vein morphologies, has allowed me to personalize my ablation approach in Medtronic cryoballoon procedures,” said Marcin Kowalski MD, Director of Electrophysiology at Staten Island University Hospital, US. “Using the two innovative technologies together has significant benefits for our patients.”
“Combining the short procedure times of cryoablation with the real-time imaging capabilities of the KODEX-EPD system, we have been able to further improve our efficient lab workflow” said Professor Lukas Dekker, Electrophysiologist at Catharina Hospital in Eindhoven, the Netherlands. “Moreover, fluoroless imaging with the KODEX-EPD system may reduce the dependency on fluoroscopy and pre-procedural CTs and thus help to reduce X-ray exposure to patients and staff, which is important to us.”
The KODEX-EPD cardiac imaging and mapping system is commercially available in the US, Europe, and China. It is part of Philips’ unique portfolio of systems, smart devices, software and services in image-guided therapy, which combine to provide healthcare providers with sophisticated, procedure-oriented solutions. More information is available at www.philips.com/epd.
[1] While using KODEX-EPD occlusion functionality, physicians should always refer to the applicable cryoballoon technical manual, published literature, and exercise their discretion to guide confirmation of pulmonary vein occlusion.
For further information, please contact:
Steve Klink
Philips Group Press Office
Tel: +31 610 888 824
Email: [email protected]
Fabienne van der Feer
Philips Image Guided Therapy
Tel: +31 622 698 001
Email: [email protected]
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachments
